The standard medical therapy of idiopathic premature ventricular complex consists of beta
blocker and Ic antiarrhythmic agent. However, the difference in the efficacy of two drugs has
not been well investigated. This prospective randomized study aimed to compare the efficacy
of beta-blocker and Ic antiarrhythmic agent in the treatment of symptomatic patients with
idiopathic premature ventricular complex.